CAIRE Acquires MGC Diagnostics Holdings

CAIRE Acquires MGC Diagnostics Holdings

Ball Ground, Georgia-based CAIRE Inc. has acquired MGC Diagnostics Holdings, Inc. MGC designs, develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems, accessories and consumables for the detection, classification and management of cardiorespiratory disease. In addition to its St. Paul, Minnesota, headquarters, MGC has facilities in Belgium, Germany, France and Australia with more than 200 employees. Global oxygen equipment manufacturer CAIRE is a leader in pioneering technologies and market solutions in support of industrial applications to benefit commercial enterprises. According to the LevinPro HC database, this represents the 107th Medical Devices... Read More »
SS Innovation Merges With Avra Medical Robotics

SS Innovation Merges With Avra Medical Robotics

SS Innovation has merged with Avra Medical Robotics. Orlando, Florida-based Avra Medical Robotics develops and manufactures surgical devices. It offers surgical robotic systems, surgical tools, implantable devices and surgical robotic training. The company develops a treatment-independent autonomous robotics system to deliver skin resurfacing treatments, such as micro-needling and laser therapies. The company was formerly known as Avra Surgical Microsystems and changed its name to Avra Medical Robotics in November 2015. SS Innovation is an Indian medtech startup founded by Dr. Sudhir Srivastava in 2016. The company aims to provide an advanced, cost-effective surgical robotic system through... Read More »
SS Innovation Merges With Avra Medical Robotics

TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation

TriSalus Life Sciences, a privately held oncology therapeutics company focused on the treatment of liver and pancreatic tumors, announced on November 14 it had entered into a definitive merger agreement with MedTech Acquisition Corporation, a publicly traded special purpose acquisition company focused on medical technology. Upon the closing of the transaction, the combined company will be a publicly traded company and its common stock is expected to be listed on the NASDAQ Stock Exchange under the ticker “TLSI”. The transaction represents a post-transaction market capitalization of approximately $244.4 million for TriSalus. At the completion of the transaction, TriSalus expects to have at... Read More »
CAIRE Acquires MGC Diagnostics Holdings

Anumana Acquires Medical Technology Company NeuTrace

Cambridge, Massachusetts-based Anumana, an AI-driven health technology company, has acquired medical technology company NeuTrace. Terms of the deal were not disclosed. Headquartered in Longwood, Florida, NeuTrace is a company advancing novel in-procedure AI applications for electrophysiology. The acquisition includes the NeuTrace EP Data Biome platform and a portfolio of AI-enabled EP software applications in development. As part of the transaction, nference acquired rights to the Data Biome platform for uses outside of the cardiovascular field. According to the LevinPro HC database, this was the 103rd Medical Devices transaction of 2022. This compares with 106 Medical Devices deals... Read More »
CAIRE Acquires MGC Diagnostics Holdings

Medical Manufacturing Technologies Acquires Confluent Medical Technologies’ Equipment Manufacturing Group

Charlotte, North Carolina-based Medical Manufacturing Technologies (MMT) has acquired Confluent Medical Technologies’ equipment manufacturing group. Terms of the deal were not disclosed. Medical Manufacturing Technologies, a portfolio company of Arcline Investment Management, is a global provider of medical device manufacturing solutions. Confluent Medical Technologies’ equipment manufacturing group includes its balloon-forming equipment manufacturing as well as its testing and catheter manufacturing equipment capabilities. Confluent’s equipment manufacturing group will be rebranded as Interface Catheter Solutions. As part of the acquisition, MMT will continue... Read More »
Johnson & Johnson Acquires Abiomed for $16.6 Billion

Johnson & Johnson Acquires Abiomed for $16.6 Billion

Johnson & Johnson acquired cardiovascular medical technology provider Abiomed, Inc. for $16.6 billion. Danvers, Massachusetts-based Abiomed has a portfolio that focuses on the treatment of coronary artery disease and heart failure and features an extensive innovation pipeline of life-saving technologies as well as an 18-year record of profitable growth. New Brunswick, New Jersey-based Johnson & Johnson is one of the largest global healthcare and pharmaceutical companies with more than 130,000 employees worldwide. Its business lines include pharmaceuticals, medical devices and consumer healthcare products. Johnson & Johnson will acquire through a tender offer all outstanding... Read More »